CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
---|---|---|
7.8 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in Microsoft Windows. It has been rated as problematic. Affected by this issue is some unknown functionality. The manipulation leads to Local Privilege Escalation. This vulnerability is handled as CVE-2011-4695. It is possible to launch the attack on the local host. There is no exploit available. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Details
A vulnerability was found in Microsoft Windows (Operating System) (the affected version is unknown). It has been declared as critical. Affected by this vulnerability is an unknown code. The manipulation with an unknown input leads to a local privilege escalation vulnerability. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
Unspecified vulnerability in Microsoft Windows 7 SP1, when Java is installed, allows local users to bypass Internet Explorer sandbox restrictions and gain privileges via unknown vectors, as demonstrated by the White Phosphorus wp_ie_sandbox_escape module for Immunity CANVAS. NOTE: as of 20111207, this disclosure has no actionable information. However, because the module author is a reliable researcher, the issue is being assigned a CVE identifier for tracking purposes.
The weakness was presented 12/07/2011 (Website). It is possible to read the advisory at lists.immunityinc.com. This vulnerability is known as CVE-2011-4695. Attacking locally is a requirement. A single authentication is needed for exploitation. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 11/28/2021).
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (71733), SecurityFocus (BID 78378†) and Vulnerability Center (SBV-54762†). See VDB-59622 for similar entry. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.8VulDB Meta Temp Score: 7.8
VulDB Base Score: 7.8
VulDB Temp Score: 7.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
AV | AC | Au | C | I | A |
---|---|---|---|---|---|
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
---|---|---|---|---|---|
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Local Privilege EscalationCWE: Unknown
CAPEC: 🔍
ATT&CK: 🔍
Local: Yes
Remote: No
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
0-Day | unlock | unlock | unlock | unlock |
---|---|---|---|---|
Today | unlock | unlock | unlock | unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/06/2011 🔍12/07/2011 🔍
12/07/2011 🔍
12/07/2011 🔍
03/23/2015 🔍
12/03/2015 🔍
11/28/2021 🔍
Sources
Vendor: microsoft.comProduct: microsoft.com
Advisory: lists.immunityinc.com
Status: Not defined
CVE: CVE-2011-4695 (🔍)
GCVE (CVE): GCVE-0-2011-4695
GCVE (VulDB): GCVE-100-59623
X-Force: 71733
SecurityFocus: 78378
Vulnerability Center: 54762 - Microsoft Windows 7 SP1 Local Privilege Escalation via Unspecified Vectors, Medium
See also: 🔍
Entry
Created: 03/23/2015 16:50Updated: 11/28/2021 07:41
Changes: 03/23/2015 16:50 (36), 04/07/2017 16:04 (9), 11/28/2021 07:36 (1), 11/28/2021 07:41 (7)
Complete: 🔍
Cache ID: 216:681:103
No comments yet. Languages: en.
Please log in to comment.